Inclusion Criteria:  Patients are between 18 to 85 years old Patient suffers from chronic stroke including hand/arm paresis and spasticity Ipsilesional motor evoked potentials (MEPs) can be evoked (EMG > 50uV) RMT of contralesional side < 70% maximum stimulator output (MSO) Patient is willing to comply with the study restrictions. Subject FMA-UE at the lesioned side is <= 60.  Exclusion Criteria  Patient is under the age of legal consent. Patient has a history of seizure disorder. Patient with intake of pro-convulsive medication, e.g. , chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, MDMA (ecstasy), phencyclidine (PCP, angel's dust), ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline, in accord with present consensus guidelines on safety, ethical considerations, and application of TMS in clinical practice and research (Rossi et al., 2009, 2021). Subject with intake of muscle-relaxing medication (e.g. baclofen, tizanidine, gabapentin,tolperisone, THC and derivates) When spasticity is treated with botox there have to be at least tree months since the last injection Patient has a cardiac pacemaker, implanted medication pump, intracardiac line, that is located close to (≤ 10 cm) to the location of activation of the TMS coil or acute, unstable cardiac disease. Patient has an intracranial implant (e.g., aneurysm clips, shunts, stimula-tors, cochlear implants, or electrodes) or any other metal object that is located close to (≤ 10 cm) to the location of activation of the TMS coil (excluding the mouth) and that cannot be safely removed. Patient has participated in another study within 2 weeks prior to the first study visit. Patient is pregnant or trying to get pregnant. Patient is unable to give informed consent. Patient is unable to understand the instructions of the FMA-UE or not motivated to follow these instructions. Patients who have contractions and therefore can't move.